Literature DB >> 222301

Plasma lipoproteins and coronary arteriography in subjects in the program on the surgical control of the hyperlipidemias. Preliminary report.

R B Moore, J M Long, J P Matts, K Amplatz, R L Varco, H Buchwald.   

Abstract

Coronary arteriographic findings, plasma lipid and lipoprotein levels, and cigarette smoking history are reported for the first 101 male post myocardial infarction survivors who have been entered into the POSCH clinical trial. Estimates of the extent of stenosis in the major coronary arteries were made using 4 models ranging from a simple determination of the number of the 3 major vessels having significant (i.e. 50% or greater stenosis) disease to more complex methods of determining overall extent of disease in 14 major segments of the coronary arteries. Age was shown to be an important factor in the extent of vessel disease. When controlling for age, plasma cholesterol and LDL-cholesterol levels were shown to be related to the extent of disease, especially in Type II hyperlipoproteinemia subjects. Multiple linear regression analysis demonstrated that age and LDL-cholesterol had positive associations and HDL-cholesterol had an inverse association with the coronary artery disease indices. In this comparatively "healthy" subgroup of the overall population of first MI survivors the major CHD risk factors are limited to plasma lipids and cigarette smoking. This preliminary report of 10% of the recruitment objective of the project supports the currently held views of the lipid--atherosclerosis hypothesis regarding the effects of age-total plasma cholesterol, LDL--cholesterol, and HDL--cholesterol on the extent of coronary atherosclerotic plaques, as determined by coronary arteriography.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 222301     DOI: 10.1016/0021-9150(79)90076-5

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  5 in total

1.  Effects and side-effects of partial ileal by-pass surgery for familial hypercholesterolaemia.

Authors:  O Faergeman; H Meinertz; E Hylander; K Fischerman; S Jarnum; O V Nielsen
Journal:  Gut       Date:  1982-07       Impact factor: 23.059

2.  Epidemiology as a guide to clinical decisions--II. Diet and coronary heart disease.

Authors:  S B Hulley; R Sherwin; M Nestle; P R Lee
Journal:  West J Med       Date:  1981-07

3.  Serum low-density lipoprotein and high-density lipoprotein cholesterol, and liver size in subjects on drugs inducing hepatic microsomal enzymes.

Authors:  P V Luoma; E A Sotaniemi; R O Pelkonen; H I Pirttiaho
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

4.  Detecting genetic effects on lipoprotein phenotypes in baboons: a review of methods and preliminary findings.

Authors:  J W MacCluer; C M Kammerer; J L VandeBerg; M L Cheng; G E Mott; H C McGill
Journal:  Genetica       Date:  1987-08-31       Impact factor: 1.082

5.  Prevention of coronary heart disease: the role of high density lipoproteins.

Authors:  N E Miller
Journal:  Postgrad Med J       Date:  1980-08       Impact factor: 2.401

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.